Screening and guidance of elderly who are admitted to the hospital (Orbis Medisch Centrum, Sittard, The Netherlands) and need special care and attention. (Screening en begeleiding van ouderen die speciale aandacht behoeven, of zorg vragen).
- Conditions
- Frail elderly people, hospitalization, prevention of unnecessary loss of functionOuderen in een kwetsbare positie, ziekenhuisopname, vermijdbare ziekenhuiscomplicaties
- Registration Number
- NL-OMON23983
- Lead Sponsor
- Orbis Medisch en Zorgconcern, Sittard, The NetherlandsMaastricht University, The Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 242
Inclusion Criteria
1. Age 70 and older;
2. GFI 4 or higher.
Exclusion Criteria
1. No informed consent;
2. Terminal illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Loss of functioning (ADL/IADL);<br /><br>2. (Unnecessary) Hospital complications;<br /><br>3. Length of stay.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie functional decline in frail elderly during hospitalization?
How does the intervention in NL-OMON23983 compare to standard-of-care for preventing hospital complications in frail elderly?
Are there specific biomarkers that identify frail elderly at highest risk for functional decline during hospitalization?
What adverse events are commonly associated with geriatric care interventions in hospitalized frail populations?
What combination approaches or supportive therapies are being explored alongside NL-OMON23983 for improving outcomes in frail elderly patients?